Results 261 to 270 of about 204,414 (356)

Correction to 'Regulation of the androgen receptor by SET9-mediated methylation'. [PDF]

Nucleic Acids Res
europepmc   +1 more source

Phosphorylation-stabilized CRTC1 cooperates with CBP and androgen receptor to transactivate AMH expression and drive polycystic ovary syndrome. [PDF]

Biol Direct
Ke Y, Zheng J, Zhang J, Tang D, Yang Q, Zhao H, Zhu C, Zhang Y.   +7 more
europepmc   +1 more source

Detection and Levels of Androgen Receptor Messenger Ribonucleic Acid in the Rat Brain by means of Reverse Transcription-Polymerase Chain Reaction.

, 1993
Takaaki Osada, Shuji Hirata, Mitsuo Hirai, Kazuki Hagihara, Junzo Kato   +4 more
openalex   +2 more sources

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania. [PDF]

BMC Cancer
Matiku S, Murenzi G, Rugengamanzi E, Liwa E, Shaban I, Orgenes A, Magorosa EP, Mwakigonja A, Vuhahula E.   +8 more
europepmc   +1 more source

Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors

, 1993
S. KUPFER, K.M. Marschke, E. WILSON, F. FRENCH   +3 more
openalex   +2 more sources

Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review

UroPrecision, EarlyView.
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj, Gautam Prasad, Mohammad Kaleem Ahmad   +2 more
wiley   +1 more source

Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader. [PDF]

Mol Cancer Ther
Snyder LB, Neklesa TK, Willard RR, Gordon DA, Pizzano J, Vitale N, Robling K, Dorso MA, Moghrabi W, Landrette S, Gedrich R, Lee SH, Taylor ICA, Houston JG.   +13 more
europepmc   +1 more source

Metastatic intrigue: Penile involvement in prostate cancer with neuroendocrine differentiation—A case report

UroPrecision, EarlyView.
Abstract Background Neuroendocrine carcinoma of the prostate is a rare tumor subtype found in the spectrum of prostate cancer, and is more difficult to detect, due to the low prostate‐specific antigen values associated with it. A high degree of suspicion is hence needed to arrive at the diagnosis in such cases.
Uttam Kumar Mete, Neha Bhardwaj, Radhika Srinivasan, Rohit Sanjay Deshpande   +3 more
wiley   +1 more source